Back to search
Neurogenic Hypertension
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Neurogenic Hypertension trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Neurogenic Hypertension trials you may qualify forAn open-label study to characterize the effects of mild, moderate, and severe Hepatic Impairment (HI) on the pharmacokinetics (PK) of ampreloxetine following a…
A double-blind study to characterize the effect of ampreloxetine on cardiac repolarization in healthy subjects.
Hypertension has always been a threat to human health, so the prevention and treatment is of great significance. At present, the treatment of primary hypertensi…